WinstonWınston
Back
Tecsys logo

Tecsys

TCS.TO
48
Software - Application · Technology
Price
C$31.00
-0.07 (-0.23%)
Market Cap
C$447.1M
Exchange
Toronto Stock Exchange
Winston Score
48
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 23, 2026 · filings through Apr 30, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Strong
Stability
Good
Valuation
Good
Dividends
Mixed

Winston Score History

The full picture

Tecsys is a Canadian software company that helps hospitals, pharmacies, and retailers manage their supply chains. Its main products are warehouse management systems, distribution software, and pharmacy inventory tools. The company is best known in healthcare supply chain software, where it serves large hospital networks and health systems across North America.

Tecsys makes money by selling software licenses and, increasingly, cloud-based subscriptions where customers pay a recurring fee each year. The company is headquartered in Montreal and operates mainly in Canada and the United States, with a small presence elsewhere. Its competitive edge comes from deep specialization in complex, regulated industries like healthcare, where switching costs are high once a hospital has built its operations around Tecsys software. The key growth driver is the ongoing shift of existing customers from older on-premise licenses to cloud subscriptions, which should lift recurring revenue over time, though the transition can temporarily pressure short-term profit margins.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.5% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

-112.9% YoY

YoY Growth Rate

Earnings declining

R&D Spend

C$33M/ year

Rising (+13% vs prior year)

17.1% of revenue

In line with sector average (15%)

Investing heavily in future products and technology

Insider Activity

20.9%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

C$34M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Heavy R&D investment

Tecsys is putting 17% of revenue into R&D and that number is rising. And they're generating enough cash to self-fund it.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

1.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 14.9M (2022) → 14.8M (2026)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
52.6%
Healthy — 52.6% gross margin
Profit after running costs
Operating Margin
1.0%
Thin — 1.0% operating margin
Return on the money invested
ROCE
10.0%
Below par — 10.0% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+9.3%
Steady sales growth (+9.3% YoY)
Profit growth
EPS YoY
-9.9%
Earnings shrinking (-9.9% YoY)

Slight earnings drop. Typical near a cyclical low.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
402%
Turns 402% of profit into real cash
Spare cash per sale
FCF Margin
5.4%
Thin free cash flow (5.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
43.63x
Comfortably covers interest (43.6x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
112.4x
Expensive — P/E 112.4

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+69.4
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (112.4 → 43.0)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend
Dividend Yield
1.16%
Small dividend — 1.16% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend record
Dividend Growth
+6.0%
Dividend growing modestly (6.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial